Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 7, 2014, Pages 1421-1431

  Krais, Annette ^a   Wortmann, Laura ^b   Hermanns, Laura ^b   Feliu, Neus ^a   Vahter, Marie ^a   Stucky, Stefan ^b   Mathur, Sanjay ^b   Fadeel, Bengt ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Biocompatibility; Folate receptor; Ovarian cancer; Superparamagnetic nanoparticles; Targeting

Indexed keywords

BIOCOMPATIBILITY; CELLS; CYTOLOGY; DISEASES; INORGANIC COATINGS; IRON OXIDES; MEDICAL NANOTECHNOLOGY; METAL NANOPARTICLES; ORGANIC ACIDS; POLYETHYLENE GLYCOLS; PROTEINS; SILICA; SILICON; SIO2 NANOPARTICLES; SURFACE CHEMISTRY;

COATED NANOPARTICLES; FOLATE RECEPTOR; IMAGING APPLICATIONS; IRON OXIDE NANOPARTICLE; OVARIAN CANCER CELLS; OVARIAN CANCERS; SUPERPARAMAGNETIC NANOPARTICLES; TARGETING;

MAGNETIC NANOPARTICLES;

FOLATE RECEPTOR 1; FOLIC ACID FUNCTIONALIZED IRON OXIDE NANOPARTICLE; IRON OXIDE POLY(ETHYLENE GLYCOL)FOLIC ACID NANOPARTICLE; IRON OXIDE SILICON DIOXIDE FOLIC ACID NANOPARTICLE; NANOCARRIER; PLASMA PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; FERRIC ION; FERRIC OXIDE; FOLIC ACID; METAL NANOPARTICLE;

ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; MACROPHAGE; OVARIAN CANCER CELL LINE; PHYSICAL CHEMISTRY; RNA INTERFERENCE; SURFACE PROPERTY; BLOOD; CHEMISTRY; FLOW CYTOMETRY; METABOLISM; OVARY TUMOR; PATHOLOGY; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE; X RAY DIFFRACTION;

BLOOD; CELL LINE, TUMOR; FEMALE; FERRIC COMPOUNDS; FLOW CYTOMETRY; FOLIC ACID; HUMANS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; OVARIAN NEOPLASMS; RNA, SMALL INTERFERING; X-RAY DIFFRACTION;

EID: 84908503564     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2014.01.006     Document Type: Article

References (36)

1. Nyström A.M., Fadeel B. Safety assessment of nanomaterials: implications for nanomedicine. J Control Release 2012, 161(2):403-408.
2. Davis M.E., Zuckerman J.E., Choi C.H.J., Seligson D., Tolcher A., Alabi C.A., et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010, 464(7291):1067-1070.
3. Hrkach J., Von Hoff D., Ali M.M., Andrianova E., Auer J., Campbell T., et al. Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci Transl Med 2012, 4(128):128ra39.
4. Monopoli M.P., Åberg C., Salvati A., Dawson K.A. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol 2012, 7(12):779-786.
5. Fadeel B., Feliu N., Vogt C., Abdelmonem A.M., Parak W.J. Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2013, 5(2):111-129.
6. Pietroiusti A., Campagnolo L., Fadeel B. Interactions of engineered nanoparticles with organs protected by internal biological barriers. Small 2013, 9(9-10):1557-1572.
7. Mahon E., Salvati A., Bombelli F.B., Lynch I., Dawson K.A. Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery". J Control Release 2012, 161(2):164-174.
8. Salvati A., Pitek A.S., Monopoli M.P., Prapainop K., Bombelli F.B., Hristov D.R., et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol 2013, 8(2):137-143.
9. Simberg D., Park J.H., Karmali P.P., Zhang W.M., Merkulov S., McCrae K., et al. Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. Biomaterials 2009, 30(23-24):3926-3933.
10. Lartigue L., Hugounenq P., Alloyeau D., Clarke S.P., Levy M., Bacri J.C., et al. Cooperative organization in iron oxide multi-core nanoparticles potentiates their efficiency as heating mediators and MRI contrast agents. ACS Nano 2012, 6(12):10935-10949.
11. Liu W., Rose J., Plantevin S., Auffan M., Bottero J.Y., Vidaud C. Protein corona formation for nanomaterials and proteins of a similar size: hard or soft corona?. Nanoscale 2013, 5(4):1658-1668.
12. Monopoli M.P., Walczyk D., Campbell A., Elia G., Lynch I., Bombelli F.B., et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 2011, 133(8):2525-2534.
13. Kunzmann A., Andersson B., Thurnherr T., Krug H., Scheynius A., Fadeel B. Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta 2011, 1810(3):361-373.
14. Bearinger J.P., Terrettaz S., Michel R., Tirelli N., Vogel H., Textor M., et al. Chemisorbed poly(propylene sulphide)-based copolymers resist biomolecular interactions. Nat Mater 2003, 2(4):259-264.
15. Prencipe G., Tabakman S.M., Welsher K., Liu Z., Goodwin A.P., Zhang L., et al. PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation. J Am Chem Soc 2009, 131(13):4783-4787.
16. Low P.S., Henne W.A., Doorneweerd D.D. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res 2008, 41(1):120-129.
17. Kilpinen S., Autio R., Ojala K., Iljin K., Bucher E., Sara H., et al. Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues. Genome Biol 2008, 9(9).
18. Garcia-Bennett A., Nees M., Fadeel B. In search of the Holy Grail: folate-targeted nanoparticles for cancer therapy. Biochem Pharmacol 2011, 81(8):976-984.
19. Yap T.A., Carden C.P., Kaye S.B. Beyond chemotherapy: targeted therapies in ovarian cancer. Nat Rev Cancer 2009, 9(3):167-181.
20. Yan A., Liu X., Qiu G., Wu H., Yi R., Zhang N., et al. Solvothermal synthesis and characterization of size-controlled Fe3O4 nanoparticles. J Alloys Compounds 2008, 458(1-2):487-491.
21. Vallhov H., Qin J., Johansson S.M., Ahlborg N., Muhammed M.A., Scheynius A., et al. The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications. Nano Lett 2006, 6(8):1682-1686.
22. Witasp E., Kupferschmidt N., Bengtsson L., Hultenby K., Smedman C., Paulie S., et al. Efficient internalization of mesoporous silica particles of different sizes by primary human macrophages without impairment of macrophage clearance of apoptotic or antibody-opsonized target cells. Toxicol Appl Pharmacol 2009, 239(3):306-319.
23. Kunzmann A., Andersson B., Vogt C., Feliu N., Ye F., Gabrielsson S., et al. Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells. Toxicol Appl Pharmacol 2011, 253(2):81-93.
24. Feliu N., Walter M.V., Montanez M.I., Kunzmann A., Hult A., Nyström A., et al. Stability and biocompatibility of a library of polyester dendrimers in comparison to polyamidoamine dendrimers. Biomaterials 2012, 33(7):1970-1981.
25. http://www.nanosafetycluster.eu/uploads/QUALITY_HANDBOOK/NANOMMUNE_QHB_FINAL_2011.pdf.
26. Neun B.W., Dobrovolskaia M.A. Detection and quantitative evaluation of endotoxin contamination in nanoparticle formulations by LAL-based assays. Mol Biol 2011, 697:121-130.
27. Yang S.T., Liu Y., Wang Y.W., Cao A. Biosafety and bioapplication of nanomaterials by designing protein-nanoparticle interactions. Small 2013, 9(9-10):1635-1653.
28. Xia W., Hilgenbrink A.R., Matteson E.L., Lockwood M.B., Cheng J.X., Low P.S. A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Blood 2009, 113(2):438-446.
29. Dobrovolskaia M.A., McNeil S.E. Immunological properties of engineered nanomaterials. Nat Nanotechnol 2007, 2(8):469-478.
30. Chao Y., Makale M., Karmali P.P., Sharikov Y., Tsigelny I., Merkulov S., et al. Recognition of dextran-superparamagnetic iron oxide nanoparticle conjugates (Feridex) via macrophage scavenger receptor charged domains. Bioconjug Chem 2012, 23(5):1003-1009.
31. Fan J.Q., Fang G., Wang X.D., Zeng F., Xiang Y.F., Wu S.Z. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles. Nanotechnology 2011, 22(45):455102.
32. Rosenholm J.M., Peuhu E., Eriksson J.E., Sahlgren C., Linden M. Targeted Intracellular delivery of hydrophobic agents using mesoporous hybrid silica nanoparticles as carrier systems. Nano Lett 2009, 9(9):3308-3311.
33. Kaaki K., Herve-Aubert K., Chiper M., Shkilnyy A., Souce M., Benoit R., et al. Magnetic nanocarriers of doxorubicin coated with poly(ethylene glycol) and folic acid: relation between coating structure, surface properties, colloidal stability, and cancer cell targeting. Langmuir 2012, 28(2):1496-1505.
34. Walkey C.D., Olsen J.B., Guo H., Emili A., Chan W.C. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc 2012, 134(4):2139-2147.
35. Sacchetti C., Motamedchaboki K., Magrini A., Palmieri G., Mattei M., Bernardini S., et al. Surface polyethylene glycol conformation influences the protein corona of polyethylene glycol-modified single-walled carbon nanotubes: potential implications on biological performance. ACS Nano 2013, 7(3):1974-1989.
36. Caracciolo G., Cardarelli F., Pozzi D., Salomone F., Maccari G., Bardi G., et al. Selective targeting capability acquired with a protein corona adsorbed on the surface of 1,2-dioleoyl-3-trimethylammonium propane/DNA nanoparticles. ACS Appl Mater Interfaces 2013, 5(24):13171-13179.